The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Bariatric surgery for non-alcoholic steatohepatitis in obese patients
Open accessAbstract
BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) is increasingly recognised as a condition associated with overweight or obesity that may progress to end-stage liver disease. NAFLD histology resembles alcohol-induced liver injury, but occurs in patients with no history of alcohol abuse. NAFLD has a broad spectrum of clinical and histological manifestations, ranging from simple fatty liver to hepatic steatosis with inflammation, advanced fibrosis, and cirrhosis. The inflammatory stage is known as non-alcoholic steatohepatitis (NASH). Recent reports indicate that weight loss induced by bariatric procedures could be beneficial for NASH treatment. OBJECTIVES: To assess the benefits and harms of bariatric surgery for NASH in obese patients. SEARCH STRATEGY: We searched The Cochrane Hepato-Biliary Group Controlled Trials Register, the Cochrane Central Register of Controlled Trials (CENTRAL) in The Cochrane Library, MEDLINE, EMBASE, and Science Citation Index Expanded to October 2009. SELECTION CRITERIA: All randomised clinical trials evaluating any bariatric procedure versus no intervention, placebo (sham procedure), or other interventions in patients with NASH regardless of publication status, number of patients randomised, language, or blinding. Quasi-randomised clinical studies were to be considered for the review if no randomised clinical trials were identified. If included, their bias towards positive findings was to be considered. DATA COLLECTION AND ANALYSIS: We extracted data in duplicate, and we planned to analyse the data by intention-to-treat. MAIN RESULTS: We could not find any randomised clinical trials or quasi-randomised clinical studies that fulfilled the inclusion criteria. Our search resulted in twenty-one prospective or retrospective cohort studies, in which improvement on steatosis or inflammation scores was reported. However, four studies also described some deterioration in the degree of fibrosis. AUTHORS' CONCLUSIONS: The lack of randomised clinical trials and quasi-randomised clinical studies precludes us to assess the benefits and harms of bariatric surgery as a therapeutic approach for patients with NASH. Limitations of all other studies with inferior design did not allow us to draw any unbiased conclusion on bariatric surgery for treatment of NASH.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series
(2008) · doi:10.1002/9780470712184 · Cited by 25,048
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
Pharmacological interventions for somatoform disorders in adults
Kleinstäuber, M., Witthöft, M., Steffanowski, A., van Marwijk, H., Hiller, W., & Lambert, M. J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010628.pub2 · Cited by 11,335
Chen, X., Xiu, M., Xing, J., Yu, S., Min, D., & Guo, F. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479439 · Cited by 5,742
Schulz (1995) · doi:10.1001/jama.1995.03520290060030 · Cited by 5,634
Nonalcoholic Steatohepatitis: A Proposal for Grading and Staging The Histological Lesions
Brunt, E. M., Janney, C. G., Di Bisceglie, A. M., Neuschwander-Tetri, B. A., & Bacon, B. R. (1999) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1999.01377.x · Cited by 3,907
Moher, D., Pham, B., Jones, A., Cook, D. J., Jadad, A. R., Moher, M., Tugwell, P., & Klassen, T. P. (1998) · The Lancet · doi:10.1016/s0140-6736(98)01085-x · Cited by 3,560
Hotamisligil, G. S., Arner, P., Caro, J. F., Atkinson, R. L., & Spiegelman, B. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117936 · Cited by 3,543
Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.
MATTEONI, C., YOUNOSSI, Z., GRAMLICH, T., BOPARAI, N., LIU, Y., & MCCULLOUGH, A. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70506-8 · Cited by 3,345
The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study
Adams, L. A., Lymp, J. F., St. Sauver, J., Sanderson, S. O., Lindor, K. D., Feldstein, A., & Angulo, P. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.04.014 · Cited by 2,890
Wood, L., Egger, M., Gluud, L. L., Schulz, K. F., Jüni, P., Altman, D. G., Gluud, C., Martin, R. M., Wood, A. J. G., & Sterne, J. A. C. (2008) · BMJ · doi:10.1136/bmj.39465.451748.ad · Cited by 2,538
Kjaergard, L. L., Villumsen, J., & Gluud, C. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-11-200112040-00010 · Cited by 2,283
Nonalcoholic Steatohepatitis: Summary of An Aasld Single Topic Conference
Neuschwander-Tetri, B. A., & Caldwell, S. H. (2003) · Hepatology · doi:10.1053/jhep.2003.50193 · Cited by 2,154
Adipose Tissue, Inflammation, and Cardiovascular Disease
Berg, A. H., & Scherer, P. E. (2005) · Circulation Research · doi:10.1161/01.res.0000163635.62927.34 · Cited by 2,113
A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis
Belfort, R., Harrison, S. A., Brown, K., Darland, C., Finch, J., Hardies, J., Balas, B., Gastaldelli, A., Tio, F., Pulcini, J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa060326 · Cited by 1,827
What to add to nothing? Use and avoidance of continuity corrections in meta‐analysis of sparse data
J. Sweeting, M., J. Sutton, A., & C. Lambert, P. (2004) · Statistics in Medicine · doi:10.1002/sim.1761 · Cited by 1,734
Bedogni, G., Miglioli, L., Masutti, F., Tiribelli, C., Marchesini, G., & Bellentani, S. (2005) · Hepatology · doi:10.1002/hep.20734 · Cited by 1,263
Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors.
Wanless, I. R., & Lentz, J. S. (1990) · Hepatology · doi:10.1002/hep.1840120505 · Cited by 1,191
Methods for combining randomized clinical trials: Strengths and limitations
Demets, D. L. (1987) · Statistics in Medicine · doi:10.1002/sim.4780060325 · Cited by 1,027
Musso, G., Gambino, R., De Michieli, F., Cassader, M., Rizzetto, M., Durazzo, M., Fagà, E., Silli, B., & Pagano, G. (2003) · Hepatology · doi:10.1053/jhep.2003.50132 · Cited by 759
Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss
Dixon, J. B., Bhathal, P. S., Hughes, N. R., & O'Brien, P. E. (2004) · Hepatology · doi:10.1002/hep.20251 · Cited by 727
Aithal, G. P., Thomas, J. A., Kaye, P. V., Lawson, A., Ryder, S. D., Spendlove, I., Austin, A. S., Freeman, J. G., Morgan, L., & Webber, J. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.06.047 · Cited by 721
Royle, P., & Milne, R. (2003) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462303000552 · Cited by 693
Clinical Features and Natural History of Nonalcoholic Steatosis Syndromes
Falck-Ytter, Y., Younossi, Z. M., Marchesini, G., & McCullough, A. J. (2001) · Seminars in Liver Disease · doi:10.1055/s-2001-12926 · Cited by 673
Adiponectin: A Novel Adipokine Linking Adipocytes and Vascular Function
Goldstein, B. J., & Scalia, R. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0518 · Cited by 647
Colquitt, J. L., Picot, J., Loveman, E., & Clegg, A. J. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003641.pub3 · Cited by 605
Effect of bariatric surgery on nonalcoholic fatty liver disease: Systematic review and meta-analysis
Mummadi, R. R., Kasturi, K. S., Chennareddygari, S., & Sood, G. K. (2008) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.08.012 · Cited by 511
Harnois, D. (2009) · Yearbook of Gastroenterology · doi:10.1016/s0739-5930(09)79298-0 · Cited by 505
Liver abnormalities in severely obese subjects: Effect of drastic weight loss after gastroplasty
Luyckx, F., Desaive, C., Thiry, A., Dewé, W., Scheen, A., Gielen, J., & Lefèbvre, P. (1998) · International Journal of Obesity · doi:10.1038/sj.ijo.0800571 · Cited by 489
Mathurin, P., Hollebecque, A., Arnalsteen, L., Buob, D., Leteurtre, E., Caiazzo, R., Pigeyre, M., Verkindt, H., Dharancy, S., Louvet, A., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.04.052 · Cited by 483
(2004) · Seminars in Liver Disease · doi:10.1055/s-2004-823098 · Cited by 481
Natural history of nonalcoholic steatohepatitis: A longitudinal study of repeat liver biopsies
Fassio, E., �lvarez, E., Dom�nguez, N., Landeira, G., & Longo, C. (2004) · Hepatology · doi:10.1002/hep.20410 · Cited by 469
Hepatic steatosis: Innocent bystander or guilty party?
Day, C. P., & James, O. F. W. (1998) · Hepatology · doi:10.1002/hep.510270601 · Cited by 388
Mattar, S. G., Velcu, L. M., Rabinovitz, M., Demetris, A. J., Krasinskas, A. M., Barinas-Mitchell, E., Eid, G. M., Ramanathan, R., Taylor, D. S., & Schauer, P. R. (2005) · Annals of Surgery · doi:10.1097/01.sla.0000179652.07502.3f · Cited by 341
Effects of surgical treatment of the metabolic syndrome on liver fibrosis and cirrhosis
Kral, J. G., Thung, S. N., Biron, S., Hould, F.-S., Lebel, S., Marceau, S., Simard, S., & Marceau, P. (2004) · Surgery · doi:10.1016/j.surg.2003.10.003 · Cited by 322
Klein, S., Mittendorfer, B., Eagon, J. C., Patterson, B., Grant, L., Feirt, N., Seki, E., Brenner, D., Korenblat, K., & McCrea, J. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.01.042 · Cited by 289
Non-alcoholic steatohepatitis: effect of Roux-en-Y gastric bypass surgery
Barker, K. B., Palekar, N. A., Bowers, S. P., Goldberg, J. E., Pulcini, J. P., & Harrison, S. A. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00419.x · Cited by 218
Dixon, J., Bhathal, P., & O'Brien, P. (2006) · Obesity Surgery · doi:10.1381/096089206778663805 · Cited by 212
Effects of bariatric surgery on nonalcoholic fatty liver disease: Preliminary findings after 2 years
Furuya, C. K., De Oliveira, C. P. M. S., De Mello, E. S., Faintuch, J., Raskovski, A., Matsuda, M., Vezozzo, D. C. P., Halpern, A., Garrido, A. B., Alves, V. A. F., et al. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.04833.x · Cited by 193
Roux‐en‐Y Gastric Bypass Improves Liver Histology in Patients with Non‐Alcoholic Fatty Liver Disease
Clark, J. M., Alkhuraishi, A. R. A., Solga, S. F., Alli, P., Diehl, A. M., & Magnuson, T. H. (2005) · Obesity Research · doi:10.1038/oby.2005.140 · Cited by 184
Regression of Hepatic Steatosis in Morbidly Obese Persons After Gastric Bypass
Silverman, E. M., Sapala, J. A., & Appelman, H. D. (1995) · American Journal of Clinical Pathology · doi:10.1093/ajcp/104.1.23 · Cited by 164
The Evolution of Severe Steatosis After Bariatric Surgery Is Related to Insulin Resistance
Mathurin, P., Gonzalez, F., Kerdraon, O., Leteurtre, E., Arnalsteen, L., Hollebecque, A., Louvet, A., Dharancy, S., Cocq, P., Jany, T., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.02.024 · Cited by 158
Clinical Hepatology: Profile of An Urban, Hospital–Based Practic
Byron, D., & Minuk, G. Y. (1996) · Hepatology · doi:10.1002/hep.510240410 · Cited by 156
Is weight reduction an effective therapy for nonalcoholic fatty liver?
Wang, R. T., Koretz, R. L., & Yee, H. F. (2003) · The American Journal of Medicine · doi:10.1016/s0002-9343(03)00449-2 · Cited by 154
The Impact of Age and Medicare Status on Bariatric Surgical Outcomes
Livingston, E. H. (2006) · Archives of Surgery · doi:10.1001/archsurg.141.11.1115 · Cited by 153
Resolution of nonalcoholic steatohepatits after gastric bypass surgery
Liu, X., Lazenby, A. J., Clements, R. H., Jhala, N., & Abrams, G. A. (2007) · Obesity Surgery · doi:10.1007/s11695-007-9086-2 · Cited by 149
Probiotics for non-alcoholic fatty liver disease and/or steatohepatitis
Lirussi, F., Mastropasqua, E., Orando, S., & Orlando, R. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005165.pub2 · Cited by 145
Trends in liver disease prevalence in Mexico from 2005 to 2050 through mortality data
Méndez‐Sánchez, N., Villa, A. R., Chávez-Tapia, N. C., Ponciano‐Rodríguez, G., Almeda‐Valdés, P., González, D., & Uribe, M. (2005) · Annals of Hepatology · doi:10.1016/s1665-2681(19)32086-1 · Cited by 129
Self-citationChanges in Liver Histology Accompanying Massive Weight Loss after Gastroplasty for Morbid Obesity
Stratopoulos, C., Papakonstantinou, A., Terzis, I., Spiliadi, C., Dimitriades, G., Komesidou, V., Kitsanta, P., Argyrakos, T., & Hadjiyannakis, E. J. (2005) · Obesity Surgery · doi:10.1381/0960892055002239 · Cited by 127
Roux-en-Y Gastric Bypass Improves the Nonalcoholic Steatohepatitis (NASH) of Morbid Obesity
Sanches, S. R. D. A., Rocha, P. S., Sanches, M. D., Leite, V. R., Pinto-Silva, R. A., Diniz, M. T. C., Diniz, M. D. F. H. S., & Rocha, A. S. (2006) · Obesity Surgery · doi:10.1381/096089206776116462 · Cited by 117
Doherty, C. (2001) · Surgical Clinics of North America · doi:10.1016/s0039-6109(05)70186-9 · Cited by 100
Mottin, C. C., Moretto, M., Padoin, A. V., Kupski, C., Swarowsky, A. M., Glock, L., Duval, V., & da Silva, J. B. (2005) · Obesity Surgery · doi:10.1381/0960892054222830 · Cited by 97
Regression of Liver Steatosis following Gastroplasty or Gastric Bypass for Morbid Obesity
Ranløv, I., & Hardt, F. (2009) · Digestion · doi:10.1159/000200499 · Cited by 89
Histological Findings in the Liver Before and After Gastric Bypass
Csendes, A., Smok, G., & Burgos, A. (2006) · Obesity Surgery · doi:10.1381/096089206776944904 · Cited by 78
Values and limitations of serum aminotransferases in clinical trials of nonalcoholic steatohepatitis
Suzuki, A., Lymp, J. F., Sauver, J. L. S., Angulo, P., & Lindor, K. D. (2006) · Liver International · doi:10.1111/j.1478-3231.2006.01362.x · Cited by 69
Prevalence of metabolic syndrome, obesity and diabetes type 2 in cryptogenic cirrhosis
Téllez-Ávila, F. I., Sánchez-Ávila, J. F., García-Saenz-de-Sicilia, M., Chávez-Tapia, N. C., Franco-Guzmán, A. M., López-Arce, G., Cerda-Contreras, E., & Uribe, M. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.4771 · Cited by 69
Self-citationNonalcoholic Fatty Liver Disease Treated by Gastroplasty
Jaśkiewicz, K., Raczyńska, S., Rzepko, R., & Śledziński, Z. (2006) · Digestive Diseases and Sciences · doi:10.1007/s10620-006-3077-3 · Cited by 62
Nonalcoholic fatty liver disease and its association with cardiovascular disease
Lizardi-Cervera, J., & Aguilar-Zapata, D. (2009) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31825-3 · Cited by 60
Self-citationKeshishian, A., Zahriya, K., & Willes, E. B. (2005) · Obesity Surgery · doi:10.1381/096089205774859290 · Cited by 57
James, O. (2002) · Medicine · doi:10.1383/medc.30.12.62.28524 · Cited by 47
Association Among C-Reactive Protein, Fatty Liver Disease, and Cardiovascular Risk
Lizardi-Cervera, J., Chávez-Tapia, N. C., Pérez-Bautista, O., Ramos, M. H., & Uribe, M. (2007) · Digestive Diseases and Sciences · doi:10.1007/s10620-006-9262-6 · Cited by 39
Self-citationBellentani, S., Bedogni, G., & Tiribelli, C. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.05.003 · Cited by 35
New insights into the pathophysiology of nonalcoholic fatty liver disease
Chávez-Tapia, N. C., Uribe, M., Ponciano‐Rodríguez, G., Medina‐Santillán, R., & Méndez‐Sánchez, N. (2009) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31821-6 · Cited by 26
Self-citationHepatic Outcomes after Jejunoileal Bypass: Is There a Publication Bias?
Meinhardt, N. G., Souto, K., Ulbrich-Kulczynski, J., & Stein, A. (2006) · Obesity Surgery · doi:10.1381/096089206778392239 · Cited by 23
Role of nonalcoholic fatty liver disease in hepatocellular carcinoma
Chávez-Tapia, N. C., Méndez‐Sánchez, N., & Uribe, M. (2009) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31824-1 · Cited by 22
Self-citationMontori, V. M., Saha, S. S., & Clarke, M. J. (2004) · Journal of General Internal Medicine · doi:10.1111/j.1525-1497.2004.41001.x · Cited by 12
Chávez-Tapia, N. C., Téllez-Ávila, F. I., Valdes-Escarcega, M., Pérez-Bautista, O., Lizardi-Cervera, J., Méndez‐Sánchez, N., Sánchez-Ávila, J. F., Ramos, M. H., & Uribe, M. (2009) · Archives of Medical Science · Cited by 3
Self-citation[Therapeuric aspects of NAFLD. A literature review].
Tapia, N. C. C., Téllez-Ávila, F. I., García-Leiva, J., Ramos, M. H., Sánchez-Ávila, J. F., & Uribe, M. (2006) · PubMed · Cited by 1
Self-citation
Cited by
Chalasani, N., Younossi, Z., Lavine, J. E., Diehl, A. M., Brunt, E. M., Cusi, K., Charlton, M., & Sanyal, A. J. (2012) · Hepatology · doi:10.1002/hep.25762 · Cited by 3,803
Chalasani, N., Younossi, Z., Lavine, J. E., Diehl, A. M., Brunt, E. M., Cusi, K., Charlton, M., & Sanyal, A. J. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.04.001 · Cited by 1,775
Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics
Polyzos, S. A., Kountouras, J., & Mantzoros, C. S. (2019) · Metabolism · doi:10.1016/j.metabol.2018.11.014 · Cited by 1,211
Cusi, K. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.02.003 · Cited by 911
Eslam, M., Sarin, S. K., Wong, V. W.-S., Fan, J.-G., Kawaguchi, T., Ahn, S. H., Zheng, M.-H., Shiha, G., Yilmaz, Y., Gani, R., et al. (2020) · Hepatology International · doi:10.1007/s12072-020-10094-2 · Cited by 833
Metadata
- Authors
- Chavez-Tapia, N. C., Tellez-Avila, F. I., Barrientos-Gutierrez, T., Mendez-Sanchez, N., Lizardi-Cervera, J., & Uribe, M.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2010-01-20
- Volume
- 2010
- Issue
- 3
- Pages
- CD007340-CD007340
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W1583545648
- Cited by
- 297
- References
- 71
- FWCI
- 24.84
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.